Gregory James Zahner, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Peripheral Arterial Disease | 13 | 2020 | 1305 | 1.970 |
Why?
|
Intermittent Claudication | 3 | 2019 | 305 | 1.160 |
Why?
|
Medicare Part C | 2 | 2022 | 322 | 1.110 |
Why?
|
Radial Artery | 3 | 2018 | 196 | 1.070 |
Why?
|
Manometry | 3 | 2018 | 453 | 1.020 |
Why?
|
Veterans Health | 2 | 2018 | 216 | 0.680 |
Why?
|
Donor Selection | 1 | 2020 | 228 | 0.640 |
Why?
|
Blood Donors | 1 | 2020 | 343 | 0.630 |
Why?
|
Vasodilation | 2 | 2018 | 962 | 0.560 |
Why?
|
Ischemia | 2 | 2020 | 1893 | 0.460 |
Why?
|
Depression | 4 | 2020 | 8045 | 0.410 |
Why?
|
Leptin | 1 | 2019 | 1590 | 0.360 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1881 | 0.330 |
Why?
|
United States Department of Veterans Affairs | 3 | 2019 | 919 | 0.250 |
Why?
|
Fatty Acids, Omega-3 | 3 | 2019 | 1387 | 0.240 |
Why?
|
Inflammation | 2 | 2019 | 10755 | 0.200 |
Why?
|
Insurance Coverage | 2 | 2022 | 1939 | 0.180 |
Why?
|
United States | 9 | 2022 | 72448 | 0.170 |
Why?
|
Cost Control | 1 | 2022 | 630 | 0.160 |
Why?
|
Cross-Sectional Studies | 6 | 2024 | 25941 | 0.160 |
Why?
|
Health Benefit Plans, Employee | 1 | 2022 | 333 | 0.160 |
Why?
|
Resistin | 1 | 2018 | 172 | 0.150 |
Why?
|
Eicosapentaenoic Acid | 2 | 2019 | 613 | 0.150 |
Why?
|
Risk Assessment | 7 | 2020 | 24102 | 0.150 |
Why?
|
Erythrocyte Membrane | 1 | 2019 | 439 | 0.150 |
Why?
|
Limb Salvage | 1 | 2019 | 465 | 0.140 |
Why?
|
Ankle Brachial Index | 1 | 2017 | 163 | 0.140 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2019 | 389 | 0.140 |
Why?
|
Education, Professional | 1 | 2017 | 51 | 0.140 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2019 | 542 | 0.130 |
Why?
|
Heart Diseases | 2 | 2018 | 2809 | 0.120 |
Why?
|
Health Expenditures | 2 | 2024 | 2362 | 0.120 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2018 | 1126 | 0.120 |
Why?
|
Aged | 14 | 2024 | 169143 | 0.120 |
Why?
|
Multivariate Analysis | 2 | 2018 | 12159 | 0.120 |
Why?
|
HIV Infections | 1 | 2020 | 17165 | 0.120 |
Why?
|
Fish Oils | 1 | 2017 | 482 | 0.110 |
Why?
|
Adiponectin | 1 | 2019 | 1114 | 0.110 |
Why?
|
Middle Aged | 13 | 2024 | 220359 | 0.100 |
Why?
|
Problem-Based Learning | 1 | 2016 | 352 | 0.100 |
Why?
|
Docosahexaenoic Acids | 1 | 2019 | 912 | 0.100 |
Why?
|
Male | 17 | 2024 | 359718 | 0.100 |
Why?
|
Vascular Surgical Procedures | 1 | 2020 | 1469 | 0.100 |
Why?
|
Affect | 1 | 2019 | 1480 | 0.100 |
Why?
|
Risk Factors | 7 | 2020 | 74333 | 0.090 |
Why?
|
Inpatients | 2 | 2020 | 2580 | 0.090 |
Why?
|
Comorbidity | 3 | 2020 | 10553 | 0.090 |
Why?
|
Critical Illness | 2 | 2020 | 2709 | 0.090 |
Why?
|
Clinical Clerkship | 1 | 2016 | 563 | 0.080 |
Why?
|
Female | 16 | 2024 | 391246 | 0.080 |
Why?
|
Interleukin-6 | 1 | 2018 | 3215 | 0.080 |
Why?
|
Linear Models | 1 | 2018 | 5877 | 0.080 |
Why?
|
Dietary Supplements | 2 | 2019 | 3392 | 0.070 |
Why?
|
Patient Discharge | 1 | 2020 | 3474 | 0.070 |
Why?
|
Databases, Factual | 2 | 2020 | 8022 | 0.070 |
Why?
|
Endovascular Procedures | 1 | 2020 | 2134 | 0.070 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2018 | 4356 | 0.070 |
Why?
|
Education, Medical, Undergraduate | 1 | 2016 | 1066 | 0.070 |
Why?
|
C-Reactive Protein | 1 | 2018 | 3839 | 0.070 |
Why?
|
Endothelium, Vascular | 1 | 2018 | 4434 | 0.070 |
Why?
|
Humans | 18 | 2024 | 760613 | 0.070 |
Why?
|
Heart Rate | 1 | 2017 | 4180 | 0.060 |
Why?
|
Mental Health | 1 | 2019 | 3213 | 0.060 |
Why?
|
Odds Ratio | 1 | 2017 | 9716 | 0.060 |
Why?
|
Veterans | 1 | 2019 | 2642 | 0.060 |
Why?
|
Cardiology | 1 | 2016 | 1723 | 0.060 |
Why?
|
Time Factors | 3 | 2020 | 40139 | 0.060 |
Why?
|
Prognosis | 3 | 2018 | 29661 | 0.050 |
Why?
|
Logistic Models | 1 | 2017 | 13312 | 0.050 |
Why?
|
Aged, 80 and over | 4 | 2020 | 58980 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15286 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2020 | 64981 | 0.050 |
Why?
|
Retrospective Studies | 5 | 2020 | 80345 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2018 | 15840 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2017 | 22052 | 0.040 |
Why?
|
Chromatography, Gas | 1 | 2019 | 151 | 0.040 |
Why?
|
Stroke | 2 | 2018 | 9952 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2020 | 15679 | 0.040 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2019 | 227 | 0.040 |
Why?
|
Arachidonic Acid | 1 | 2019 | 433 | 0.040 |
Why?
|
Kaplan-Meier Estimate | 2 | 2018 | 6544 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2018 | 11890 | 0.040 |
Why?
|
Neoplasms | 2 | 2024 | 22075 | 0.030 |
Why?
|
Hospitals, Veterans | 1 | 2018 | 398 | 0.030 |
Why?
|
Placebos | 1 | 2019 | 1668 | 0.030 |
Why?
|
Myocardial Revascularization | 1 | 2018 | 841 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2018 | 12531 | 0.030 |
Why?
|
Curriculum | 2 | 2017 | 3718 | 0.030 |
Why?
|
California | 1 | 2017 | 1416 | 0.030 |
Why?
|
Frail Elderly | 1 | 2018 | 752 | 0.030 |
Why?
|
Administration, Oral | 1 | 2019 | 4035 | 0.020 |
Why?
|
Mentors | 1 | 2016 | 661 | 0.020 |
Why?
|
Geriatric Assessment | 1 | 2018 | 1405 | 0.020 |
Why?
|
Program Development | 1 | 2016 | 1297 | 0.020 |
Why?
|
Up-Regulation | 1 | 2018 | 4122 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2016 | 2659 | 0.020 |
Why?
|
Program Evaluation | 1 | 2016 | 2493 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10546 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 2018 | 2890 | 0.020 |
Why?
|
Chronic Disease | 1 | 2020 | 9288 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2019 | 12427 | 0.010 |
Why?
|
Quality Improvement | 1 | 2016 | 3835 | 0.010 |
Why?
|
Quality of Life | 1 | 2021 | 13308 | 0.010 |
Why?
|
Incidence | 1 | 2018 | 21391 | 0.010 |
Why?
|
Cohort Studies | 1 | 2018 | 41337 | 0.010 |
Why?
|
Adult | 1 | 2024 | 220007 | 0.010 |
Why?
|